The cuts come fast following Edward Lifesciences' earnings miss last night: ``We no longer have confidence in management executing on the US launch,'' says RBC, cutting its PT to $72 from $102.
The cuts come fast following Edward Lifesciences' (ew) earnings miss last night: ``We no longer